Abiraterone acetate plus ADT most cost effective option for metastatic prostate cancer in the USA
Source: PharmacoEconomics and Outcomes News - Category: Drugs & Pharmacology Source Type: news
More News: Abiraterone Acetate | Cancer | Cancer & Oncology | Drugs & Pharmacology | Prostate Cancer